Posted by Sarah Showard | May 20, 2016 | 0 Comments

A recent study published in the online issue of Neurology, the medical journal of the American Academy of Neurology indicates that the multiple Sclerosis drug mitoxantrone may be associated with an increased risk of colorectal cancer.  The drug is prescribed for aggressive types of relapsing remitting or progressive MS that don't respond to other MS drugs.  It has previously been linked to an increased risk of leukemia and heart damage so is not widely prescribed. 

The study, conducted in Germany examined whether mitoxantrone increases the risk of cancers other than leukemia and involved 676 people who were treated with mitoxantrone from 1994-2007 and were followed until 2010.  37 people (5.5%) were diagnosed with cancer.  9 people were diagnosed with breast cancer, 7 with colorectal cancer and 4 with acute myeloid leukemia.  The rate of leukemia was 10 times higher than in the general population, colorectal cancer was 3 times higher and breast cancer had no increased risk over the general population.  Because the overall rate of cancer is still low, the study author, Mathias Buttmann, M.D., the use of mitoxantrone may still be justified for people severely affected by MS if there is no better treatment available and that if the results are confirmed colonoscopies should be given after treatment with the drug to screen for colorectal cancer in order to detect and treat it early. 

About the Author

Sarah Showard

Sarah Showard graduated from the University of Maryland in 1985, Magna Cum Laude with a Bachelor of Arts in English-Linguistics and a Certification in Womens Studies. She then graduated from New York University School of Law in 1988. Sarah began practice initially as an insurance defense attorne...


There are no comments for this post. Be the first and Add your Comment below.

Leave a Comment

Showard Law Firm-Tucson's Local Law Firm for defective drug & medical device claims.

Showard 20staff 202017 201026 20special 20edit edit.jpg 20small

Showard Law Firm is dedicated to compassionate representation for our clients who have been injured by defective products, dangerous drugs or the negligence of any individual or company. We are experienced in litigation and ready to ensure you receive the maximum possible settlement for your injuries, medical bills, mental anguish and other losses.

Sarah Showard and Dr. Peter Ott - 2018 Heart Ball Chairs


Sarah and Peter are the proud chairs of this year's Heart and Stroke Ball, held on 2/17/18 at the El Conquistador. With a western theme "Heart of the West", this important fund raiser is in its 60th year, all raising funds to help with research and advances in the case against heart disease in the Tucson community.